Yi Chen

机构：Fujian Medical University, Ministry of Education of the People's Republic of China, Shanxi Medical University, Fudan University, Ministry of Education, Mengchao Hepatobiliary Hospital, First Hospital of Shanxi Medical University, Zhongshan Hospital, Ministry of Education, Union Hospital · ORCID：0000-0003-3262-3627

发表论文 53 篇 · 总被引 603 次 · h-index 12

代表论文

• Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study (2023 · Signal Transduction and Targeted Therapy · 被引 156)
• The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion (2022 · Hepatology International · 被引 35)
• Complement C3 mediates podocyte injury through TLR4/NFΚB-P65 signaling during ischemia–reperfusion acute kidney injury and post-injury fibrosis (2023 · European journal of medical research · 被引 15)
• Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis (2024 · mSystems · 被引 14)
• C3a/C3aR synergies with TGF-β to promote epithelial-mesenchymal transition of renal tubular epithelial cells via the activation of the NLRP3 inflammasome (2023 · Journal of Translational Medicine · 被引 12)
• Acute kidney injury in patients with idiopathic membranous nephropathy: influencing factors and prognosis (2023 · Renal Failure · 被引 12)